Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentRole of HIV in amyloid metabolismChronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceEndothelin-1 and its role in the pathogenesis of infectious diseasesGenetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersCognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.Viruses and autophagyβ-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide AEfavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.HIV-1 stimulates nuclear entry of amyloid beta via dynamin dependent EEA1 and TGF-β/Smad signaling.HIV-1 Transactivator Protein Induces ZO-1 and Neprilysin Dysfunction in Brain Endothelial Cells via the Ras Signaling Pathway.Pathogenesis of HIV in the central nervous systemCerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditionsActivation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection.Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection.Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesisTranscriptional profile of HIV-induced nuclear translocation of amyloid β in brain endothelial cells.Intraindividual variability in HIV infection: evidence for greater neurocognitive dispersion in older HIV seropositive adults.Autophagy in dementias.Family history of dementia predicts worse neuropsychological functioning among HIV-infected personsCombined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switchingLipid rafts and functional caveolae regulate HIV-induced amyloid beta accumulation in brain endothelial cells.Phenylbutyric acid suppresses protein accumulation-mediated ER stress in retrovirus-infected astrocytes and delays onset of paralysis in infected micePlatelet decline as a predictor of brain injury in HIV infection.HIV-1 gp120 induces type-1 programmed cell death through ER stress employing IRE1α, JNK and AP-1 pathway.11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorderAge-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transferCerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice.Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and MiceApolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disordersCurrent understanding of HIV-associated neurocognitive disorders pathogenesis.Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders.Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production.Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia
P2860
Q26766448-E356F6FB-FFEB-47E8-AFAA-15D852335D8BQ26824179-77F62178-8838-4782-B490-DFB9D2D6EF07Q26825762-1C2D8A52-9C88-4CEE-A6BB-63807A49F387Q26830339-8A8ED917-67DA-485F-9447-F9025AEBCF77Q26865707-43DBDC62-130A-48A2-91FB-A947940D54F6Q27025573-66D8B212-56DE-4B77-A22D-40061F94A102Q27311532-AA901F55-11FA-4ACD-B39F-529A6FA0F61BQ27491341-BA0BC102-0B95-4955-8C15-7E6B64BD382AQ28545117-18F6DCAE-79F0-4730-9610-6576355E6924Q31159582-1385551F-984E-482E-9154-268A707BFA53Q33520347-66C2730E-36A8-4488-B5A0-134484A19E0AQ33604503-87F5F496-0004-48A7-A0BE-6CD2F6C65B7FQ33695622-139D16D7-FB9D-4F26-B3B0-20470AB35B28Q33781978-3B3C0784-474A-4DC6-AC48-AD3CCC8C5446Q33863368-33FE646C-EF6C-44D5-A4EC-381FBDB764A9Q33980117-F4AA8AED-17E1-447F-B46A-4DE0D3811239Q34067393-7B6A3AD1-998C-4C07-AD98-6624B39A61B2Q34125271-7FA571EF-1BA3-4AB9-9269-18905254234BQ34540333-5EA8A905-595D-43FB-95C8-5E72EAC1DCC6Q34805533-A4F949D0-D6EF-4C80-8B02-6B025405E225Q35032667-330AD022-3B30-4B49-A415-41414D00E2D0Q35072502-DF70BAAF-CD68-4205-9E0B-D16CBC0710ACQ35171279-95D2A3A9-5E5E-47E9-8455-35B93209D9D7Q35624697-66886808-1942-41CD-85D1-32F03A59079BQ35756142-F03C125D-152B-40ED-A3C1-1B9D792956E4Q35897499-3306A80A-DFC7-4188-BAB9-E728CB04A55DQ35947300-BA27D2A3-0FC5-44BE-AE23-ADE2631FF8E8Q36108977-71A66ADE-410F-4249-B709-5A7781D4A554Q36320562-E2203215-06E5-4706-ABE0-A84644D60452Q36438349-DAA6B0A7-A9B5-4917-A7EB-C2DF47BBC87FQ36507182-BD9FE79D-B5B2-4F78-A401-58B971BB26B2Q36595284-F5FBE9E9-8D34-447D-A414-DFB2512C3CC3Q36622848-6D7636FA-7B52-4B44-9C23-CE285C42FB9AQ36718290-70AE5A8B-E5A5-4B5D-A6A2-DA9513225136Q36821772-DD900A45-AF99-4CB8-94FC-CA9662EA259AQ36890788-80B47356-765F-403E-9307-56F06E98C6DAQ36932005-E84F0196-CEFB-4FDA-8450-2AF98B842067Q36989549-CA728124-9B37-466F-BA62-ED2F6E905B9EQ36997333-05D4B5D7-45EC-406E-9053-0A271DA12204Q37026506-41373E7B-74C7-4B22-B5DF-3FC0A6A0F1D1
P2860
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@ast
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@en
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@nl
type
label
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@ast
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@en
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@nl
prefLabel
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@ast
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@en
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@nl
P2093
P2860
P1476
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
@en
P2093
Anthony Adame
Cristian L Achim
Ian P Everall
Neurobehavioral Research Center
Wilmar Dumaop
P2860
P2888
P304
P356
10.1007/S11481-009-9152-8
P577
2009-03-17T00:00:00Z
P5875
P6179
1003592067